Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops algorithms for generating therapeutic monoclonal antibodies, particularly targeting GPCRs. Their technology aims to simplify the antibody development process for researchers seeking new protein therapeutics.